| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,196 |
4,687 |
$310K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,643 |
6,249 |
$286K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,820 |
1,257 |
$48K |
| 87430 |
|
1,223 |
1,147 |
$22K |
| 80053 |
Comprehensive metabolic panel |
1,678 |
1,436 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,487 |
1,193 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,786 |
1,513 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
203 |
194 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
242 |
227 |
$10K |
| 81003 |
|
2,476 |
2,248 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
286 |
263 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
177 |
139 |
$3K |
| 83735 |
|
323 |
299 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
41 |
38 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
43 |
42 |
$780.78 |
| 83690 |
|
101 |
94 |
$690.54 |
| 82150 |
|
101 |
94 |
$689.40 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
157 |
140 |
$651.03 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
59 |
50 |
$592.16 |
| 71045 |
Radiologic examination, chest; single view |
121 |
117 |
$562.78 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13 |
12 |
$473.99 |
| 81025 |
|
102 |
99 |
$387.99 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
342 |
322 |
$367.23 |
| 87503 |
|
41 |
38 |
$331.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$322.03 |
| 80061 |
Lipid panel |
14 |
14 |
$244.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
185 |
155 |
$190.54 |
| 82553 |
|
13 |
13 |
$187.11 |
| 36415 |
Collection of venous blood by venipuncture |
213 |
140 |
$132.35 |
| 82550 |
|
14 |
14 |
$115.20 |
| 84484 |
|
13 |
13 |
$112.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$4.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
95 |
86 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12 |
12 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
67 |
58 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
405 |
92 |
$0.00 |